Limited benefits from cidofovir therapy combined with reduced immunosuppression in clinically-evident BK nephropathy in renal transplants. Poster presentation at the 2004 American Transplant Congress,

Research output: Other contribution (Published)Other contribution

Original languageEnglish (Ireland)
Media of outputConference Poster
Place of PublicationBoston, MA.
Publication statusPublished - 1 Jan 2004

Cite this